Skip to main content
Fig. 6 | Journal of Nanobiotechnology

Fig. 6

From: A clinical trial of super-stable homogeneous lipiodol-nanoICG formulation-guided precise fluorescent laparoscopic hepatocellular carcinoma resection

Fig. 6

The surgical navigation effect of SHIFT&nanoICG after TAE-assisted therapy. A The 3D reconstruction imaging before hepatectomy showed that the tumor was located in the right posterior lobe of the liver and was closely connected to the surrounding blood vessels. B The fluorescence imaging of primary lesion. C The fluorescence imaging of the incisal margin of the residual liver, with achieved R0 resection. D–F Whole resected tumor lesions and fluorescence imaging (white arrowhead = primary lesion, red arrowhead = microsatellite lesion). G–I The dissected tumor lesion and fluorescence imaging (white arrowhead = primary lesion, red arrowhead = microsatellite lesion). J–L The dissected tumor lesion by layer and fluorescence imaging. M–N The microsatellite lesion and fluorescence imaging. O The H&E staining of microsatellite lesion

Back to article page